Novo Nordisk submitted a New Drug Application to the FDA on December 18, 2025, with FDA review expected during 2026
Dry mouth (xerostomia) is a side effect experienced by some individuals using GLP-1 receptor agonist injections for weight loss treatment
2010s: Tesamorelin research expanded into liver fat, body composition, and metabolic markers
When choosing a supplement, prioritize acetyl-L-carnitine for its superior absorption and brain health benefits
Muscle loss with aging called sarcopenia already happens naturally
Innate Immun 24(4):221230 Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM et al (2011) CD14 controls the LPS-induced endocytosis of Toll-like receptor 4